Growth Metrics

Rigel Pharmaceuticals (RIGL) Shareholder's Equity Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Rigel Pharmaceuticals 551.62 Mn 404.94 Mn 54.21 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2,053.81%
Dec 31, 2025 11,806.33%
Sep 30, 2025 903.56%
Jun 30, 2025 373.90%
Mar 31, 2025 158.62%
Dec 31, 2024 111.48%
Sep 30, 2024 54.02%
Jun 30, 2024 -6.40%
Mar 31, 2024 -30.56%
Dec 31, 2023 -110.37%
Sep 30, 2023 -60.50%
Jun 30, 2023 -664.62%
Mar 31, 2023 -456.83%
Dec 31, 2022 -144.83%
Sep 30, 2022 -139.93%
Jun 30, 2022 -105.40%
Mar 31, 2022 -91.32%
Dec 31, 2021 -10.73%
Sep 30, 2021 -2.52%
Jun 30, 2021 7.75%
Mar 31, 2021 -0.26%
Dec 31, 2020 -36.77%
Sep 30, 2020 -26.06%
Jun 30, 2020 -19.26%
Mar 31, 2020 -17.64%
Dec 31, 2019 -51.02%
Sep 30, 2019 -33.40%
Jun 30, 2019 -36.64%
Mar 31, 2019 19.43%
Dec 31, 2018 9.17%
Sep 30, 2018 84.22%
Jun 30, 2018 77.53%
Mar 31, 2018 -5.08%
Dec 31, 2017 82.90%
Sep 30, 2017 -14.82%
Jun 30, 2017 -5.58%
Mar 31, 2017 11.44%
Dec 31, 2016 -39.78%
Sep 30, 2016 -31.60%
Jun 30, 2016 -27.12%
Mar 31, 2016 -32.72%
Dec 31, 2015 -28.75%
Sep 30, 2015 -34.35%
Jun 30, 2015 -38.97%
Mar 31, 2015 -40.45%
Dec 31, 2014 -38.42%
Sep 30, 2014 -34.27%
Jun 30, 2014 -32.37%
Mar 31, 2014 -29.02%
Dec 31, 2013 -27.96%
Sep 30, 2013 27.80%
Jun 30, 2013 25.19%
Mar 31, 2013 22.50%
Dec 31, 2012 22.42%
Sep 30, 2012 -32.24%
Jun 30, 2012 -28.21%
Dec 31, 2011 42.15%